急性呼吸或心力衰竭接受体外膜氧合治疗的危重患者研究核心结局指标:一项国际多学科改良德尔菲共识研究
该研究采用三轮改良德尔菲法,纳入患者、照护者、多学科临床医生、研究人员、产业伙伴和研究资助者,代表五大洲10个国家的关键体外膜氧合组织。将系统综述和幸存者定性研究识别的结局指标分别映射到静脉-静脉和静脉-动脉体外膜氧合的COMET域。三轮调查应答率分别为40/47(85%)、35/37(95%)、64/69(93%)。第三轮后,8项结局指标在静脉-静脉和静脉-动脉体外膜氧合均达成共识。该共识首次允许体外膜氧合研究结局报告标准化,下一步是确定合适的测量工具。
要点
- 国际改良德尔菲共识确定8项核心结局指标,适用于所有评估静脉-静脉或静脉-动脉体外膜氧合的研究。
- 共识纳入患者、照护者、多学科临床医生、研究人员、产业伙伴和研究资助者,代表五大洲10个国家。
- 三轮调查应答率分别为40/47(85%)、35/37(95%)、64/69(93%)。
- 核心结局包括体外膜氧合干预特有的不良事件,首次实现结局报告标准化。
- 下一步是确定评估这些核心结局的合适测量工具,以促进体外膜氧合研究合成。
适用人群与场景
- 接受静脉-静脉或静脉-动脉体外膜氧合治疗的急性呼吸或心力衰竭危重患者。
- 研究纳入患者、照护者、多学科临床医生、研究人员、产业伙伴和研究资助者。
研究设计与关键结果
- 研究类型为三轮改良德尔菲共识研究,参与者代表五大洲10个国家的关键体外膜氧合组织。
- 三轮调查应答率分别为40/47(85%)、35/37(95%)、64/69(93%)。
- 第三轮调查后,8项结局指标在静脉-静脉和静脉-动脉体外膜氧合均达成共识。
证据类型、等级与局限
- 证据类型为国际多学科改良德尔菲共识研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该共识确定的8项核心结局指标可用于所有评估静脉-静脉或静脉-动脉体外膜氧合的研究,实现结局报告标准化。
- 作者认为,确定评估这些核心结局的合适测量工具是重要的下一步,以促进体外膜氧合研究的合成。
指南或共识出处
- Core Outcome Measures for Research in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation for Acute Respiratory or Cardiac Failure: An International, Multidisciplinary, Modified Delphi Consensus Study(Critical Care Medicine)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Research evaluating outcomes in critically ill patients with acute respiratory and cardiac failure supported with extracorporeal membrane oxygenation has increased significantly. The objective was to identify a core set of outcomes that are essential to include in all clinical research evaluating the use of either venoarterial or venovenous extracorporeal membrane oxygenation in critically ill patients, particularly regarding safety and adverse events.
DESIGN: A three-round modified Delphi process.
SUBJECTS: Patients, caregivers, multidisciplinary clinicians, researchers, industry partners, and research funders were included.
SETTING: Participants represented key extracorporeal membrane oxygenation organizations, including the Extracorporeal Life Support Organization, the International Extracorporeal Membrane Oxygenation Network, clinicians from high volume extracorporeal membrane oxygenation centers, and extracorporeal membrane oxygenation researchers or former extracorporeal membrane oxygenation patients from five continents.
INTERVENTIONS: We used recommended standards for the development of a core outcome set. Outcome measures identified from systematic reviews of the literature and from qualitative studies of survivors were mapped to the domains identified by the Core Outcome Measures in Effectiveness Trials initiative separately for venovenous extracorporeal membrane oxygenation and venoarterial extracorporeal membrane oxygenation.
MEASUREMENTS AND MAIN RESULTS: Participant response rates were 40 of 47 (85%), 35 of 37 (95%), and 64 of 69 (93%) for survey rounds 1, 2, and 3, respectively, with participants representing 10 different countries on five continents. After the third round survey, 8 outcome measures met consensus for both venovenous extracorporeal membrane oxygenation and venoarterial extracorporeal membrane oxygenation.
CONCLUSIONS: This study identified core outcomes to assess in all research evaluating the use of extracorporeal membrane oxygenation, including adverse events specific to this intervention, permitting standardization of outcome reporting for the first time. Identifying appropriate measurement instruments to evaluate these outcomes is an important next step to enable synthesis of extracorporeal membrane oxygenation research.
参考来源
- Hodgson CL, Burrell AJC, Engeler DM, et al. Core Outcome Measures for Research in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation for Acute Respiratory or Cardiac Failure: An International, Multidisciplinary, Modified Delphi Consensus Study. Crit Care Med. 2019. PMID: 31389837. doi:10.1097/CCM.0000000000003954
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。